Perhaps the initial panic selling of Monogram Biosciences stock this morning shouldn't be surprising. Monogram manufactures a diagnostic test used to identify HIV patients who would respond to Pfizer Inc's maraviroc drug, which didn't get the expected FDA approval on June 20.
Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Follow on https://twitter.com/peterrost
Thursday, June 21, 2007
Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug
Labels:
maraviroc,
Monogram Biosciences,
Pfizer Inc
Subscribe to:
Post Comments (Atom)
2 comments:
dr. rost,
any interesting mail this past weekend?
hmmm cryptic...I know everyone knows Pfizer has been propping Monogram up for quite awhile so in reality what you have is a paper tiger without Pfizer they may be caput....
Post a Comment